Current and Former Staff of the Animal Resources Division, Health Canada 2001 Study James Brooks CIHR/CBS Post Doctoral Research Fellow Erling Rud Head,

Slides:



Advertisements
Similar presentations
Development of a Panel for Dengue Virus Maria Rios, PhD CBER/FDA Blood Products Advisory Committee Meeting December 14, 2010.
Advertisements

Endemic or Outbreak? Differentiating recent transmission of an historic tuberculosis strain in New York City IUATLD-NAR 16 th Annual Meeting February 23-25,
AMMI Canada /CPHA Co-developed Accredited Learning Activity December 3, 2014 Dat Tran, MD, MSc Staff Physician, Division of Infectious Diseases The Hospital.
* Ebola virus disease (EVD), formerly known as Ebola hemorrhagic fever, is a severe, often fatal illness in humans. * EBOLA is a rare but deadly virus.
Ebola Virus Status Update; Personal Protective Equipment October 24, 2014.
What is Ebola? 10/12/2014. What is Ebola? Filoviridae Ebolavirus – 5 viruses/species – Ebola (Zaire) – Sudan – Bundibugyo – Tai Forest – Reston Marburgvirus.
Page Up to Reverse  Employee Health  Page Down to Advance  Employee Health 
INTEGRATED RABIES EPIDEMIOLOGY IN REMOTE INUIT COMMUNITIES IN QUÉBEC, CANADA: A “ONE HEALTH” APPROACH C. Aenishaenslin, A. Simon, T. Forde, A. Ravel, J-F.
Ebola Virus. What is Ebola hemorrhagic fever? Ebola hemorrhagic fever (Ebola HF) is a severe, often-fatal disease in humans and nonhuman primates (monkeys,
A housing first program operated by St. Vincent de Paul of Baltimore
Implementing screening for acute HIV infection in STD clinics already using rapid HIV antibody testing, New York City, 2007 Kathleen D. Gallagher, MPH.
Outbreak of Mycobacterium tuberculosis Among Employees of an Elephant Refuge Rendi Murphree, PhD CDR, USPHS Tennessee Department of Health EIS Field Assignments.
Mosquito-borne Arbovirus Surveillance in West Virginia Rachel Radcliffe, DVM, MPH CDC Career Epidemiology Field Officer Division of Infectious Disease.
Perinatal Hepatitis B Prevention
ANIMAL MODELS HIV Cure Research Training Curriculum The HIV CURE training curriculum is a collaborative project aimed at making HIV cure research science.
THE OCCUPATIONAL HEALTH PROGRAM FOR ANIMAL RELATED ACTIVITIES KATHRYN WIENS – INTERIM OCCUPATIONAL HEALTH PROGRAM ADMINISTRATOR.
Working Safely with Nonhuman Primates Training 2015 edition.
CDC Investigations Relevant to Potential for Simian Foamy Virus Transmission by Transfusion Louisa Chapman, MD, MSPH OD, DASTLR, NCID, CDC & HIV and Retrovirology.
Director Deputy Director National Institute for Occupational Safety and Health Office of Surveillance, Epi, and Lab Services Office of Non- communicable.
Chlamydia Sexually Transmitted Disease Surveillance 2000 Division of STD Prevention.
Curable versus incurable STDs. Objectives To describe the natural history and epidemiology of two curable STDs (i.e. syphilis and chlamydia) and two non-
Network modeling of the Ebola Outbreak Ahmet Aksoy.
Can we prevent infection after an exposure
Viruses: genetic elements encased in protein Viruses cannot reproduce independently: they are missing several of the characteristics of living organisms.
Dengue Fever Guillermo Mata. Dengue fever also known as break bone fever, is an infectious tropical disease caused by the dengue virus.
MRSA in Corrections Danae Bixler, MD, MPH
Jace Dyckman RiverStone Health JEOPARDY!
Adult Viral Hepatitis Update Roxanne Ereth, MPH, BS Hepatitis C Program Manager Adult Viral Hepatitis Prevention Coordinator.
DEPARTMENT OF HEALTH RESEARCH INSTITUTE FOR TROPICAL MEDICINE Ebola Reston in the Philippines Catalino S. Demetria, DVM.
Viral Hepatitis - Historical Perspective A “Infectious” “Serum” Viral hepatitis Entericallytransmitted Parenterallytransmitted F, G, ? other E NANB BD.
EBOLA VIRUS FREQUENTLY ASKED QUESTIONS. What is Ebola virus disease? (Formerly Ebola haemorrhagic fever)- a severe, often fatal illness, with a DEATH.
Occupational Health and Animal Use Gary L.White, D.V.M., M.M.S. Division of Animal Resources University of Oklahoma Health Sciences Center.
Funded by the European UnionContract No. FP6-RII
Kathleen Orloski, DVM, MS Diplomate, ACVPM, Epidemiology Specialty USDA, APHIS, Veterinary Services TB Eradication Program April 5-6, 2011.
Simian Foamy Viruses (SFV) Arifa S. Khan, Ph.D. DVP, OVRR, CBER, FDA BPAC, December 13, 2001.
Studies of HIV Eradication: a Case for Using NHP Models Guido Silvestri, MD Yerkes National Primate Research Center Emory University School of Medicine.
Update on Assay Development George J. Dawson, Ph.D. Infectious Diseases: Core R & D Abbott Laboratories West Nile Virus.
Epidemiology With Respect to the Dynamics of Infectious Diseases Huaizhi Chen.
An Update on FDA/OBRR XMRV activities BPAC meeting, July 26, 2010 Indira Hewlett, Ph. D Chief, Laboratory of Molecular Virology DETTD/CBER/FDA.
Viral Tissue Reservoirs Are Determined Early and Little Viral RNA Is Detected during Suppression in the Macaque Model Zandrea Ambrose, Ph.D. Division of.
OCCUPATIONAL EXPOSURES TO HIV AMONG HEALTHCARE WORKERS IN CANADA McCarthy G. M.¹, Harris K. A.¹, John M. A.², Stitt L. W.¹ ¹Schulich School of Medicine.
Welcome to “STD 101 in a Box” Developed by Centers for Disease Control and Prevention National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention.
CDC Guidelines for Use of QuantiFERON ® -TB Gold Test Philip LoBue, MD Centers for Disease Control and Prevention Division of Tuberculosis Elimination.
Sexually Transmitted Disease Prevention 101 Presented by Lora Lock RN and Tessa Dillon RN Nova Southeastern University.
Screening the US Workforce for Skin Cancer: The National Health Interview Survey 1997 to 2003 Caban-Martinez AJ 1, Lee DJ 1,3, Fleming LE 1, LeBlanc WG.
Trends in HIV diagnoses in Ontario, 2000­2004 Robert S. Remis, Jane Njihia, Carol Swantee, Maraki Fikre Merid Ontario HIV Epidemiologic Monitoring Unit,
12C 10 MARCH to 1996 became internationally recognized….. Ebola Different Types This research is about the causes, treatment and prevention.
Outbreaks and Epidemics Ebola Hemorrhagic Fever. Ebola facts and origins  Ebola hemorrhagic fever is a severe, often-fatal disease in humans and nonhuman.
John J. Lanza, MD, PhD, MPH, FAAP Florida Department of Health A Public and Clinical Health Perspective.
FLORIDA HOSPITAL-EMPLOYEE HEALTH PREVENTION OF SHARPS INJURIES AND EXPOSURE TO BLOOD AND BODY FLUIDS MICHELLE SCARLETT AND MARIE DECEUS.
Treatment Failure HAIVN Harvard Medical School AIDS Initiative in Vietnam.
Public Health Perspective on SARS Diagnostics Stephen M. Ostroff Deputy Director National Center for Infectious Diseases, CDC.
Proposed Animal Study to Evaluate Simian Foamy Virus (SFV) Transmission by Blood Arifa S. Khan, Ph.D. DVP, OVRR, CBER, FDA BPAC, December 13, 2001.
CONCLUSIONS New Jersey’s Emergency Department HIV testing sites report higher seroprevalence than non-ED testing sites. Since University Hospital began.
Immunity –Disease – any change that disrupts body’s internal regulation (homeostasis) –Pathogen – anything that causes disease  Ex. Virus, bacteria, fungi,
Abbott Laboratories ConfidentialPage 1 Update on West Nile Virus George J. Dawson, Ph.D. Abbott Laboratories.
Q fever from Unknown Febrile Patients in Korea
1University of Kentucky, Lexington, Kentucky
Leslie Nordgren, MPH Susan Gerberich, PhD Bruce Alexander, PhD
Table 1: NHBS HET3 Participant Characteristics
POST EXPOSURE PROPHYLAXIS IN HCW
APIC Greater new York Chapter 13
CDC Guidelines for Use of QuantiFERON®-TB Gold Test
Xenoinfection of nonhuman primates by feline immunodeficiency virus
EBOLA VIRUS INFORMATION
Ebola Outbreak – summary of an Honors Thesis from Stanford University Copyright 1999 by Tara Waterman Reston, VA Hazelton Research Products (currently.
Study of HIV-2 in monkey Pigtail macaque (Macaca nemestrina) Baboons
OCCUPATIONAL EXPOSURES TO HIV AMONG HEALTHCARE WORKERS IN CANADA
Centers for Disease Control and Prevention guidelines for evaluating the risk of HIV transmission after occupational exposure (PEP, post-exposure prophylaxis).
Presentation transcript:

Current and Former Staff of the Animal Resources Division, Health Canada 2001 Study James Brooks CIHR/CBS Post Doctoral Research Fellow Erling Rud Head, Clinical Research, Animal Resources Division, HPFB Paul Sandstrom Associate Director Bureau of HIV/AIDS, STD & TB, CIDPC Simian Foamy Virus Infection Among Individuals Occupationally Exposed to Non Human Primates

Outline Rationale for the Health Canada SFV Study Trends in primate importation/utilization Description of Health Canada Animal Resources Division primate colony Results of Health Canada Study of Human SFV Infection Among Animal Workers

Background Macaque spp. have historically been among the most common NHP’s used in research Currently cynomolgus macaques (Macaca fascicularis) represent the vast majority of imported NHP’s Despite frequent occupational exposure there had not been a documented case of human SFV infection originating from macaques

Last 2 years importation of NHP in U.S.A. (1999, N = 12,744; 2000, N = 12,061) Source: Tom Damercus, Division of Quarantine, National Center for Infectious Disease, Centers for Disease Control and Prevention # of non-human primates N = 12,744N = 12,061

Species of NHP used in Canada ( ) N = 1373 N = 2150N = 1,621N = 875 N = 1,131

Study Objective To screen for human SFV infection of macaque origin using assays optimized for macaque SFV

Health Canada Primate Colony 875 Cynomolgus macaques imported from the Philippines Currently houses approximately 240 monkeys Previously housed up to 1200 monkeys Prior to 1983 a mixture of cynomolgus and rhesus macaques Herpes B free colony 80% seropositive for SFV

Average Monthly NHP Colony Population by Year Number of animals

Study Design Anonymous, un-linked convenience sample of workers having contact with non-human primates or their blood and tissues Screened using immunoblot Target antigen SFV1, SFV3, SFV6 & SFV-HC infected cell culture lysates Confirmation using PCR amplification from PBLs of a 153 bp fragment located within the pol gene

Occupations of Study Participants

Characteristics of Study Participants Average age 45 years M:F Ratio 56:44 Average of 13 years of exposure to Cynomolgus macaques Average of 10 years of exposure to Rhesus macaques

Person Years of Exposure to NHP Species

Exposure Patterns

Total Number of Bites Reported By Species

Results of SFV Study 2 out of the 46 participants have positive serological tests for foamy virus infection (4% of study participants) 1 of the 46 participants has been confirmed as infected with SFV by PCR from PBLs Preliminary evidence suggests that this human SFV infection is of macaque origin

SFV HC/1/3/6 Infected Cell Lysates Cf2Th/BHK21 Uninfected Host Cell Lysates Representative Screening Immunoblot ChimpAGMCynoBaboonHuman 1Human MW kDa

Exposure Histories of SFV Infected Humans Both individuals report : –prolonged and ongoing exposure to cynomolgus macaques –previous exposure to rhesus macaques –events involving exposure to blood and/or body fluids, including bites, scratches or surgical injuries, from macaque species

env pol gag LTR Accessory Genes SFV Genome Structure taf Location of 153 bp PCR Fragment in pol gene

0.05 c1f c3f Human 1 c10f SFV 1 (macaque) Hamlyn’s guenon African Green Monkey SFV 3 Drill Mandrill Patas Monkey Papio urinus Baboon Papio anubis Papio cynocephalus Gorilla Chimpanzee HFV Neighbor-Joining Phylogenetic Analysis Courtesy of William Switzer, CDC

Pattern of Blood Donation 3% of eligible Canadians donate blood on a regular basis (Canadian Blood Services) 54% (25/46)of study participants reported at least one donation of blood or blood products ever. 88% (22/25) of Animal workers that reported blood donation also reported bites by NHP’s

Canadian Institutes of Health Research Canadian Blood Services Health Canada, CIDPC, PPHB Dr. Paul Gully Dr. Donald Sutherland Rick Pilon Chris Scherf Health Canada, HPFB Dr. Jocelyn Fournier University of Ottawa Dr Francisco Diaz-Mitoma Esoterix Inc. Dr. Richard Heberling Acknowledgements